|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, September 26, 2018 ) This report covers the present scenario (with the base year being 2017) and the growth prospects of global Spinal Cord Stimulation Devices market for 2018-2023.
A Spinal Cord Stimulator (SCS) or Dorsal Column Stimulator (DCS) is a type of implantable neuromodulation device (sometimes called a "pain pacemaker") that is used to send electrical signals to select areas of the spinal cord (dorsal columns) for the treatment of certain pain conditions. SCS is a consideration for people who have a pain condition that has not responded to more conservative therapy. The classification of spinal cord stimulation devices includes rechargeable type and Non-Rechargeable type. The proportion of rechargeable type in 2017 is about 66%, and the proportion is in increasing trend from 2013 to 2017.Spinal cord stimulation devices is widely used in failed back surgery syndrome, complex regional pain syndrome, chronic pain and other field. The most proportion of spinal cord stimulation devices is for failed back surgery syndrome, and the proportion in 2017 is 42%. North America is the largest supplier of Spinal Cord Stimulation Devices, with a production market share nearly 87% in 2017. Europe is the second largest supplier of Spinal Cord Stimulation Devices, enjoying production market share nearly 13% in 2017.Medtronic, Boston Scientific, Abbott (St. Jude Medical), Nevro, Nuvectra are the leaders of the industry. And Top 3 account for around 78% of the total market share. These existing companies are making investments in several research activities to launch new devices.
Over the next five years projects that Spinal Cord Stimulation Devices will register a 5.6% CAGR in terms of revenue, reach US$ 2980 million by 2023, from US$ 2150 million in 2017.
Get Sample Copy@ https://www.qurateresearch.com/report/sample/MnE/QBI-LPI-MnE-52427
This report presents a comprehensive overview, market shares, and growth opportunities of Spinal Cord Stimulation Devices market by product type, application, key manufacturers and key regions.
To calculate the market size experts considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Rechargeable
Non-Rechargeable
Segmentation by application:
Failed Back Surgery Syndrome
Complex Regional Pain Syndrome
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Enquiry about Report@ https://www.qurateresearch.com/report/enquiry/MnE/QBI-LPI-MnE-52427
Table of Content:
2018-2023 Global Spinal Cord Stimulation Devices Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Spinal Cord Stimulation Devices Consumption 2013-2023
2.1.2 Spinal Cord Stimulation Devices Consumption CAGR by Region
2.2 Spinal Cord Stimulation Devices Segment by Type
2.2.1 Rechargeable
2.2.2 Non-Rechargeable
2.3 Spinal Cord Stimulation Devices Consumption by Type
2.3.1 Global Spinal Cord Stimulation Devices Consumption Market Share by Type (2013-2018)
2.3.2 Global Spinal Cord Stimulation Devices Revenue and Market Share by Type (2013-2018)
2.3.3 Global Spinal Cord Stimulation Devices Sale Price by Type (2013-2018)
2.4 Spinal Cord Stimulation Devices Segment by Application
Get Exclusive Discount@ https://www.qurateresearch.com/report/discount/MnE/QBI-LPI-MnE-52427
Qurate Business Intelligence
Nehal Chinoy
+919881074592
nehal@qurateresearch.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
